GE HealthCare Technologies's latest marketcap:
As of 06/26/2025, GE HealthCare Technologies's market capitalization has reached $33.31 B. According to our data, GE HealthCare Technologies is the 654th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 33.31 B |
| Revenue (ttm) | 19.8 B |
| Net Income (ttm) | 2.18 B |
| Shares Out | 457.88 M |
| EPS (ttm) | 4.76 |
| Forward PE | 18.20 |
| Ex-Dividend Date | 04/25/2025 |
| Earnings Date | 07/30/2025 |
GE HealthCare Technologies's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | $33.31 B | -8.78% | 654 |
| 12/31/2024 | $35.72 B | 1.47% | 546 |
| 12/29/2023 | $35.2 B | 32.6% | 517 |
| 12/30/2022 | $26.55 B | 636 |
Company Profile
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. is a global leader in the development, manufacturing, and marketing of innovative medical products, services, and digital solutions. The company specializes in diagnostic, therapeutic, and patient monitoring technologies, serving healthcare providers in the United States, Canada, and internationally.
Business Segments
- Imaging – Offers advanced imaging solutions, including molecular imaging, CT scanning, MR imaging, X-ray systems, and women’s health products.
- Advanced Visualization Solutions (AVS) – Provides ultrasound, image-guided therapies, and interventional solutions for disease screening, diagnosis, and treatment.
- Patient Care Solutions (PCS) – Delivers medical devices, consumables, and digital solutions for patient monitoring, diagnostic cardiology, anesthesia, and maternal care.
- Pharmaceutical Diagnostics (PDx) – Supplies contrast media and radiopharmaceuticals for enhanced imaging in radiology and nuclear medicine.
Key Offerings
- Diagnostic imaging systems (CT, MRI, X-ray)
- Ultrasound and image-guided therapy solutions
- Patient monitoring and anesthesia products
- Contrast agents and molecular imaging pharmaceuticals
Company Background
Formerly known as GE Healthcare Holding LLC, the company rebranded as GE HealthCare Technologies Inc. in December 2022. Founded in 2022, it is headquartered in Chicago, Illinois.
Frequently Asked Questions
-
What is GE HealthCare Technologies's (GEHC) current market cap?As of 06/26/2025, GE HealthCare Technologies (including the parent company, if applicable) has an estimated market capitalization of $33.31 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does GE HealthCare Technologies (GEHC) rank globally by market cap?GE HealthCare Technologies global market capitalization ranking is approximately 654 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.